Table 2
Complications of Medpor LES
| Aetiology | Overall complication rate | Major complications | Minor complications | Final outcome of eyelids where implant retained |
|---|---|---|---|---|
| All eyelids (n = 35) | 17/35 (49%) eyelids | 8/35 (23%) eyelids | 9/35 (26%) eyelids | n = 29 |
| Good: 83% | ||||
| Satisfactory: 17% | ||||
| Facial palsy (n = 12) | 4 (33%) | 2/12 (16%) | 2/12 (16%) | 9/10 good |
| 1 removed for pain; 1 extruded | 1 lid tightening, 1 declined revision | 1/10 satisfactory | ||
| Graves’ orbitopathy (n = 10) | 6 (60%) | 2/10 (20%) | 4/10 (40%) | 8/9 good, 4 after revision |
| 1 removed (poor motility); 1 exchange (superior edge ridge) | 1 margin ectropion; 2 superior edge ridge (1 patient); 1 transient lash loss | 1/9, lost to follow up after 15 months | ||
| Ocular prosthesis instability (n = 7) | 3/7 (43%) | 1/7 (14%) Removed after exposure | 3/7 (43%) All superior edge ridge | 4/6 good, 1 after revision 2/6 satisfactory; 1 revised, 1 declined revision |
| Myotonic/muscular dystrophy (n = 3) | 2/3 (66%) | 2/3 (66%) exposed: Both revised (same patient) | 0/3 | 1/3 good 2/3 satisfactory, both revised |
| Maxillectomy with radiotherapy (n = 2) | 1/2 (50%) | 1/2 (50%) 1 removed | 0/2 | 1/1 good without further surgery |
| Chemical injury to eyelids (n = 1) | 0 (0%) | 0/1 | 0/1 | 1/1 good |
